Department of Pharmacy, Peking University School and Hospital of Stomatology, Beijing 100081, China.
International Research Center for Medicinal Administration, Peking University, Beijing 100191, China.
Int J Environ Res Public Health. 2021 Nov 15;18(22):11966. doi: 10.3390/ijerph182211966.
Full coverage policies for medicines have been implemented worldwide to alleviate medicine cost burden and promote access to medicines. However, few studies have explored the factors associated with free medicine use in patients with chronic diseases. This study aimed to analyze the utilization of free medicines by patients with hypertension and diabetes after the implementation of the full coverage policy for essential medicines (FCPEM) in Taizhou, China, and to explore the factors associated with free medicine use. We conducted a descriptive analysis of characteristics of patients with and without free medicine use and performed a panel logit model to examine factors associated with free medicine use, based on an electronic health record database in Taizhou from the baseline year (12 months in priori) to three years after FCPEM implementation. After FCPEM implementation, the proportion of patients without any free medicine use decreased from 31.1% in the baseline year to 28.9% in the third year, while that of patients taking free medicines rose from 11.0% to 22.8%. Patients with lower income or education level, those with agricultural , patients aged 65 and above, married patients, and patients in the Huangyan district were more likely to take free medicines. In conclusion, FCPEM contributed to improved medicine access, especially in vulnerable populations. Local policy makers should consider expanding the coverage of FCPEM to other types of medicines and cultivate the potential of social supports for patients to enhance the effectiveness of FCPEM policies.
已在全球范围内实施了药品全覆盖政策,以减轻医药费用负担并促进药品可及性。然而,很少有研究探讨与慢性病患者免费使用药物相关的因素。本研究旨在分析中国台州实施基本药物全覆盖政策(FCPEM)后高血压和糖尿病患者对免费药物的使用情况,并探讨与免费药物使用相关的因素。我们对使用和不使用免费药物的患者的特征进行了描述性分析,并基于台州电子健康记录数据库,在 FCPEM 实施前的基线年度(12 个月)至三年后,进行了面板逻辑模型分析,以检验与免费药物使用相关的因素。FCPEM 实施后,无任何免费药物使用的患者比例从基线年度的 31.1%下降到第三年的 28.9%,而使用免费药物的患者比例从 11.0%上升到 22.8%。收入或教育水平较低、农业户籍、65 岁及以上、已婚和黄岩区的患者更有可能使用免费药物。总之,FCPEM 有助于改善药物可及性,特别是在弱势群体中。地方政策制定者应考虑将 FCPEM 覆盖范围扩大到其他类型的药物,并培养社会支持患者的潜力,以增强 FCPEM 政策的有效性。